Cargando…

Emergence of Mucormycosis during COVID-19 Pandemic and Dermatological Manifestations

Detalles Bibliográficos
Autores principales:	Vinay, Keshavamurthy, Rudramurthy, Shivaprakash M., Dogra, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354408/ https://www.ncbi.nlm.nih.gov/pubmed/34430451 http://dx.doi.org/10.4103/idoj.idoj_406_21

Ejemplares similares

Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis
por: Kaur, Harsimran, et al.
Publicado: (2021)

Antifungal Drug Susceptibility Testing of Dermatophytes: Laboratory Findings to Clinical Implications
por: Dogra, Sunil, et al.
Publicado: (2019)

Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2020)

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021)

Dermatoscopy in Skin of Color: How Different are We?
por: Dogra, Sunil, et al.
Publicado: (2021)

Rituximab in Pemphigus: Road Covered and Challenges Ahead
por: Vinay, Keshavamurthy, et al.
Publicado: (2018)

Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2021)

Mucormycosis and COVID-19: manifestations of the central nervous system and the ocular system
por: Polo Martínez, Michelle Ariana, et al.
Publicado: (2022)

Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients
por: Ghosh, Anup K., et al.
Publicado: (2022)

Indian Dermatology Online Journal (IDOJ) Going the Print Way!
por: Dogra, Sunil
Publicado: (2018)

Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2023)

Dermatology and COVID-19: The Hidden Pandemic
por: Recalcati, S., et al.
Publicado: (2022)

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
por: Hoenigl, Martin, et al.
Publicado: (2022)

A pictorial review of imaging manifestations of rhino-orbito-cerebral mucormycosis–emerging threat in COVID pandemic
por: Aggarwal, Ankita, et al.
Publicado: (2022)

Dermatological Manifestation due to Preventive Measures Used During COVID-19 Pandemic
por: Agrawal, Sandip, et al.
Publicado: (2020)

Dermatologic manifestations of multisystem inflammatory syndrome in children during the COVID-19 pandemic()
por: Baykal Selçuk, Leyla, et al.
Publicado: (2023)

Reconceptualizing dermatology patient care and education during the COVID-19 pandemic and beyond
por: Lipner, Shari R., et al.
Publicado: (2021)

S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients
por: Honnavar, Prasanna, et al.
Publicado: (2022)

Molecular Identification and Quantification of Malassezia Species Isolated from Pityriasis Versicolor
por: Honnavar, Prasanna, et al.
Publicado: (2020)

Comprehensive Taxonomical Analysis of Trichophyton mentagrophytes/interdigitale Complex of Human and Animal Origin from India
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2023)

Role of Cutaneous Microbiome in Dermatology
por: Mustari, Akash P., et al.
Publicado: (2023)

COVID-19 and Dermatology
por: Das, Anupam
Publicado: (2021)

Dermatologic manifestations and complications of COVID-19
por: Gottlieb, Michael, et al.
Publicado: (2020)

Dermatological Manifestations of COVID-19 in Children
por: Panda, Maitreyee, et al.
Publicado: (2022)

The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
por: Gupta, Amod, et al.
Publicado: (2021)

Resurgence of mucormycosis during COVID-19 pandemic
por: Ali, Kamran, et al.
Publicado: (2022)

Surge of mucormycosis during the COVID-19 pandemic
por: Dam, Paulami, et al.
Publicado: (2023)

COVID-19 associated mucormycosis a deadly disease within the pandemic
por: Giraddi, Girish B
Publicado: (2021)

COVID-19-associated mucormycosis: Looking for the culprit!
por: Larcher, Romaric, et al.
Publicado: (2021)

P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022)

Inequities in the emergence, manifestations and consequences of COVID19
por: Mendez, Fabian
Publicado: (2021)

Dermatological Manifestations Associated with COVID-19 Infection
por: Panda, Maitreyee, et al.
Publicado: (2021)

Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
por: Muthu, Valliappan, et al.
Publicado: (2022)

Association of Malassezia species with dandruff
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2014)

COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic
por: Chamola, Vinay, et al.
Publicado: (2022)

Covid-associated pulmonary mucormycosis
por: Kumar, Arvind, et al.
Publicado: (2022)

Procedural Dermatology during COVID-19 Pandemic
por: Sinha, Anwita, et al.
Publicado: (2021)

Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
por: Poplausky, Dina, et al.
Publicado: (2023)

Angioedema and COVID-19: A New Dermatological Manifestation?
por: Royer, Pierre-Yves, et al.
Publicado: (2021)

Dermatologic Manifestation of Acro-Ischemia Associated With COVID-19
por: Gumbita, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gumdr337puvpemv1b6fkkboms